China approves Pfizer GLP-1 drug for weight loss

By Andrew Silver SHANGHAI, March 6 (Reuters) - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight ...
AASTOCKS.com

Pfizer's Weight Loss Injection GLP-1 Ecnoglutide Injection Approved in CN

Pfizer China announced that the National Medical Products Administration (NMPA) has officially approved the new-generation ...
Malaysia Sun

Pfizer's weight-loss injection cleared in Chinese market

China has approved Pfizer's GLP-1 drug Xianweiying for long-term weight management in overweight or obese adults, the U.S. drugmaker said ...
Hosted on MSN

Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial

Pfizer said its experimental obesity drug, which it acquired through Metsera, drove solid weight loss when taken once a month in a mid-stage trial. The data offer early evidence that the injection can ...

China Clears Weight-Loss Shot As Pfizer Enters Crowded Market

China's National Medical Products Administration has approved Pfizer Inc.’s PFE ecnoglutide injection for chronic weight management in adults with overweight or obesity, marking the first approval of ...

Sciwind Biosciences Partners with Pfizer China to Commercialize its Biased GLP-1 in China

Hangzhou Sciwind Biosciences Co., Ltd. (Sciwind Biosciences) today announced a strategic commercialization collaboration with Pfizer China for Ecnoglutide injection (Ecnoglutide), a new–generation ...